eyeforpharma is now Reuters Events - LEARN MORE
Close log in window
Gene replacement and cell-based therapies are here to cure, but are we ready for them? The current difficulty pricing groundbreaking healthc...
Individualised medicine has so far failed to live up to the hype but innovations in the field are on the cusp of disrupting the way pharma a...
Compassionate use programs offer hope to patients who have ran out of options. But the benefits must be weighed against the risks.